The company said the results from the evoke study, which tested an oral semaglutide pill for early-stage symptomatic Alzheimer's disease, were "not what we had hoped for"
The collaborations aim to accelerate the discovery of new therapeutic candidates, particularly in oncology and neurology, by combining next-generation AI platforms with...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.